Skip to main content

1243 results

Publication

Buyback programs - december 2023

Monthly communication regarding buyback programs
Publication

Buyback programs - october 2023

Monthly communication regarding buyback programs
Publication

Sales 3rd quarter 2023: 136M€

The Vetoquinol Group posted sales of €136 million in Q3 2023, up +1.3% on a reported basis and +5.1% at constant exchange rates. Over the same period, Vetoquinol recorded a negative currency impact of -€5 million, linked to the Americas and Asia Pacific/Rest of World territories.
News

Sales 3rd quarter 2024

9-month sales: €398 million (+1.8% at constant exchange rates and +1.6% on a reported basis) 9-month sales of essential products: €241million (+3.9% at constant exchange rates and on a reported basis) At the end of September 2024, Vetoquinol sales totaled €398 million, up +1.6% on a reported basis...
News

Sales 3rd quarter 2023

Q3 Sales: €136m (+5.1% at constant exchange rates) Q3 Essentials Sales: €81m (+12.2% at constant exchange rates) Matthieu Frechin, Chairman and CEO of Vetoquinol, commented: "Our sales in Q3 2023 were marked by a dynamic activity and stronger negative currency impacts than in the first half. In a...
Publication

Buyback programs - September 2023 (french)

Monthly communication regarding buyback programs
Publication

Monthly information regarding the total number of voting rights and shares making of the share capital - September 2023

As per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »
News

90 years - Sustainable development, an integral part of Vetoquinol

Vetoquinol's corporate vision underlines its ambition for its entire ecosystem. This vision creates a dynamic for sustainable development by stating that by 2033 the company will be "the most agile animal health laboratory where employees, experts, partners, and customers work together to create...
Publication

Sustainable development, an integral part of Vetoquinol

Vetoquinol's corporate vision underlines its ambition for its entire ecosystem. This vision creates a dynamic for sustainable development by stating that by 2033 the company will be "the most agile animal health laboratory where employees, experts, partners, and customers work together to create...
Publication

Rapport financier semestriel 2023 (french)

Rapport financier semestriel 2023 (french)